Mantle-cell lymphoma: A population-based clinical study

Journal of Clinical Oncology

Volumn 14, Issue 4, 1996, Pages 1269-1274

  Velders, G A ^a   Kluin Nelemans, J C ^a   De Boer, C J ^a   Hermans, J ^a   Noordijk, E M ^a   Schuuring, E ^a   Kramer, M H ^a   Van Deijk, W A ^a   Rahder, J B ^a   Kluin, P M ^a   Van Krieken, J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BONE MARROW METASTASIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 9244264929     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.4.1269     Document Type: Article

References (31)

1. Banks PM, Chan J, Clearry ML, et al: Mantle cell lymphoma. Am J Surg Pathol 16:637-640, 1992
2. Raffeid M, Jaffe ES: Bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 78:259-263, 1991
3. Jaffe ES, Bookman MA, Longo DL: Lymphocytic lymphoma of intermediate differentiation-mantle zone lymphoma. Hum Pathol 18:877-880, 1987
4. Weisenburger DD: Mantle cell lymphoma, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD, Williams & Wilkins, 1992, pp 617-628
5. Shivdasani RA, Hess JL, Skarin AT, et al: Intermediate lymphocytic lymphoma: Clinical and pathological features of a recently characterized subtype of non-Hodgkin's lymphoma. J Clin Oncol 11:802-811, 1993
6. Berger F, Felman P, Sonet A, et al: Nonfollicular small B-cell lymphomas: A heterogeneous group of patients with distinct clinical features and outcome. Blood 83:2829-2835, 1994
7. Lennert K: Centrocytic lymphoma, in Lennert K (ed): Histopathology of Non-Hodgkin's Lymphoma (based on the Kiel classification). New York, NY, Springer-Verlag, 1981, pp 57-62
8. Nathwani BN: A critical analysis of the classification of non-Hodgkin's lymphomas. Cancer 44:347-384, 1979
9. Weisenburger DD, Nathwani BN, Diamond LW, et al: Malignant lymphoma of intermediate lymphocytic type. Cancer 48:1415-1425, 1981
10. Non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
11. Lardelli P, Bookman MA, Sundeen J, et al: Lymphocytic lymphoma of intermediate differentiation. Am J Surg Pathol 14:752-763, 1990
12. Weisenburger DD, Sanger WG, Armitage JO, et al: Intermediate lymphocytic lymphoma: Immunophenotypic and cytogenetic findings. Blood 69:1617-1621, 1987
13. Weisenburger DD, Linder J, Daley DT, et al: Intermediate lymphocytic lymphoma. Human Pathol 18:781-790, 1987
14. Bookman MA, Lardelli P, Jaffe ES, et al: Lymphocytic lymphoma of intermediate differentiation: Morphologic, immunophenotypic, and prognostic factors. J Natl Cancer Inst 82:742-748, 1990
15. Raffeld M, Sander CA, Yano T, et al: Mantle cell lymphoma: An update. Leuk Lymphoma 8:161-166, 1992
16. Medeiros J, Van Krieken JHJM, Jaffe ES, et al: Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood 76:2086-2090, 1990
17. Williams ME, Swerdlow SH, Meeker TC: Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia 7:1437-1440, 1993
18. Bérard CW, Dorfman RF: Histopathology of malignant lymphoma. Clin Haematol 3:39-76, 1974
19. Narang S, Wolf BC, Neiman RS: Malignant lymphoma presenting with prominent splenomegaly. A clinicopathologic study with special refence to intermediate cell lymphoma. Cancer 55:1948-1957, 1985
20. Zucca E, Fontana S, Roggero E, et al: Treatment and prognosis of centrocytic (mantle cell) lymphoma: A retrospective analysis of 26 patients treated in one institution. Leuk Lymphoma 13:105-110, 1994
21. Zucca E, Stein H, Coiffier B: European Lymphoma Task Force (ELTF): Report of the workshop on mantle cell lymphoma (MCL). Ann Oncol 5:507-511, 1994
22. Otter R, Gerrits WBJ, Sandt MM vd, et al: Primary extranodal and nodal non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol 25:1203-1210, 1989
23. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
24. De Boer CJ, Loyson S, Kluin PM, et al: Multiple breakpoints within the BCL-1 locus in B-cell lymphoma rearrangements of the cyclin D1 gene. Cancer Res 53:4148-4152, 1993
25. De Boer CJ, Schuuring E, Dreef E, et al: Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 86:2715-2723, 1995
26. Lukas J, Pagano M, Staskova Z, et al: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9:707-718, 1994
27. Bartkova J, Lukas J, Strauss M, et al: Cell cycle-related variation and tissue restricted expression of human cyclin D1 protein. J Pathol 172:237-245, 1994
28. Grogan TM, Lippman SM, Spier CM, et al: Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood 71:1157-1160, 1988
29. Bosch F, Jares P, Campo E, et al: PRAD-1/Cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma. Blood 84:2726-2732, 1994
30. Leith CP, Spier CM, Grogan TM, et al: Diffuse small cleaved-cell lymphoma: A heterogeneous disease with distinct immunobiologic subsets. J Clin Oncol 10:1259-1265, 1992
31. Meusers P, Engelhard M, Bartels H: Multicenter randomized therapeutical trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis. Hematol Oncol 7:365-380, 1989